Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ATRFG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-PRLR-Ab-LP2-P12
|
|||||
| Synonyms |
Anti-PRLR-Ab LP2 P12
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Anti-PRLR mAb
|
Antibody Info | ||||
| Antigen Name |
Prolactin receptor (PRLR)
|
Antigen Info | ||||
| Payload Name |
Budesonide derivative P12
|
Payload Info | ||||
| Therapeutic Target |
Glucocorticoid receptor (NR3C1)
|
Target Info | ||||
| Linker Name |
DIBAC-suc-PEG4-Val-Cit-PAB
|
Linker Info | ||||
| Conjugate Type |
The conjugation is microbial transglutaminase (MTG)-mediated attachment of linker to the antibodies. Site-specific conjugations were performed using N297Q-mutated antibody.
|
|||||
